Driving Smarter Chemistry In Drug Discovery: Using Full DEL Data To Improve Early Compound Decisions
High-throughput screening produces far more insight than a simple list of hits, yet much of that information is often left unexplored. When teams focus narrowly on individual compounds, they risk overlooking broader patterns that can shape smarter chemistry decisions earlier in discovery. Examine how analyzing screening data across related compounds can uncover meaningful structure–function relationships. By viewing results in context—rather than in isolation—scientists gain a clearer picture of how chemical features influence biological response. That perspective helps distinguish promising series from those less likely to succeed, reducing wasted effort downstream.
Find out how a more holistic view of screening data supports prioritization, sharpens design strategies, and strengthens decision-making across discovery programs.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.